These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17702137)

  • 1. [Cost of medication in the Czech Republic--causes of growth in costs and solution proposals].
    Zigová Z
    Vnitr Lek; 2007 Jun; 53(6):760-74. PubMed ID: 17702137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improvement in the results of treatment of selected blood diseases and changes in the costs of such treatment. Issues for economists and other experts].
    Adam Z; Vorlícek J; Korístek Z; Adamová Z
    Vnitr Lek; 2007 Jun; 53(6):735-49. PubMed ID: 17702135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacoeconomy of diabetes mellitus--trends in the Czech Republic].
    Horák P
    Vnitr Lek; 2009 Apr; 55(4):331-40. PubMed ID: 19449745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost of medications in the oncology sector in the context of health economics].
    Walter E; Batista A
    Wien Med Wochenschr; 2008; 158(7-8):227-33. PubMed ID: 18500477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in mental health cost growth: an expanded role for management?
    Frank RG; Goldman HH; McGuire TG
    Health Aff (Millwood); 2009; 28(3):649-59. PubMed ID: 19414870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care system in the Czech Republic.
    Spacilova L; Petrelli F; Grappasonni I; Scuri S
    Ann Ig; 2007; 19(6):573-81. PubMed ID: 18376578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costs of type II diabetes in the conditions of the Czech Republic's medical care system].
    Dolezal T; Písaríková Z; Zemanová P; Bartásková D
    Vnitr Lek; 2009 Apr; 55(4):342-4. PubMed ID: 19449746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charging systems for municipal solid waste: experience from the Czech Republic.
    Sauer P; Parízková L; Hadrabová A
    Waste Manag; 2008 Dec; 28(12):2772-7. PubMed ID: 18804364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Price development of oral contraceptives].
    Minarcíková I
    Ceska Slov Farm; 2005 Sep; 54(5):220-5. PubMed ID: 16209436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Health and money].
    Holcík J
    Cas Lek Cesk; 2004; 143(1):4-8. PubMed ID: 15061111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical expenditure, total health-care expenditure and GDP.
    Clemente J; Marcuello C; Montañés A
    Health Econ; 2008 Oct; 17(10):1187-206. PubMed ID: 18050150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicaid managed care and the distribution of societal costs for persons with severe mental illness.
    Shern DL; Jones K; Chen HJ; Jordan N; Ramoni-Perazzi J; Boothroyd RA
    Am J Psychiatry; 2008 Feb; 165(2):254-60. PubMed ID: 18198269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of primary care in colorectal cancer screening: experience from Czech Republic.
    Seifert B; Zavoral M; Fric P; Bencko V
    Neoplasma; 2008; 55(1):74-80. PubMed ID: 18190246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
    Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
    Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does public insurance provide better financial protection against rising health care costs for families of children with special health care needs?
    Yu H; Dick AW; Szilagyi PG
    Med Care; 2008 Oct; 46(10):1064-70. PubMed ID: 18815528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of drug utilization of most commonly used drugs in Poland and Czech Republic.
    Ruszczyńska E; Biba V; Stika L; Czarnecki A
    Acta Pol Pharm; 1998; 55(4):323-7. PubMed ID: 9821399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comment on the article by Z. Skodová et al: Decrease in cardiovascular disease mortality in the Czech Republic 1984-1993 and its causes].
    Widimský J
    Cas Lek Cesk; 1998 Apr; 137(8):248-50. PubMed ID: 9650351
    [No Abstract]   [Full Text] [Related]  

  • 19. [Editorial in response to the article by D. Cechurová et al.: "Economic aspects of the diabetic foot syndrome"].
    Jirkovská A
    Vnitr Lek; 2003 Jun; 49(6):439-41. PubMed ID: 14503468
    [No Abstract]   [Full Text] [Related]  

  • 20. Physician payment 2008 for interventionalists: current state of health care policy.
    Manchikanti L; Giordano J
    Pain Physician; 2007 Sep; 10(5):607-26. PubMed ID: 17876359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.